Savills PLC
26 August 2026
SAVILLS PLC (THE "COMPANY")
TRANSACTION IN SHARES BY DIRECTORS AND PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES (PDMRS)
Grant of Share Awards
The Company announces that on 25 August 2026 awards have been made to Directors and PDMRs of the Company as follows under the Performance Share Plan:
|
Director / PDMR |
Number of Shares subject to the Performance Share Plan awarded to the Director / PDMR on 25 August 2026 |
Total number of shares subject to the Performance Share Plan following this notification |
|
Simon Shaw (Director) |
75,471 |
120,467 |
|
Nick Sanderson (Director) |
52,830 |
52,830 |
|
Chris Lee (PDMR) |
22,712 |
45,482 |
The Performance Share Plan provides for the award of nil cost options or conditional awards of ordinary shares in the Company.
Awards of shares are made subject to a three-year performance period. Awards which satisfy the applicable performance criteria (as below) in the three-year performance period will then vest after an additional two-year holding period.
Awards vest subject to the satisfaction of the following performance criteria measured over the three years to 31 December 2028:
(a) one-third of the initial value of an award is subject to the Company's Total Shareholder Return ('TSR') performance measured against the TSR of the FTSE Mid 250 Index (excluding investment trusts);
(b) a further one-third of the initial value of an award is subject to Group Earnings per Share ('EPS') performance; and
(c) the final one-third of the initial value of an award is subject to the three-year average Return on Capital Employed ('ROCE') of the Company.
Awards vest as follows:
(a) for the TSR linked part of an award, 25% (i.e. threshold) will vest if the Company's TSR matches Index performance, rising to 100% (i.e. maximum) if the Company's TSR outperforms the Index by 8% p.a., compound or more with sliding scale vesting between the two points;
(b) for the EPS growth linked part of an award, 25% (i.e. threshold) will vest if the Company's EPS growth over the period is 6% p.a. compound, rising to 100% (i.e. maximum) if the Company's EPS growth over the period is 18% p.a. compound or more with sliding scale vesting between the two points; and
(c) for the ROCE linked part of an award, 25% (i.e. threshold) will vest if the Company's 3-year average ROCE over 2026-28 (inclusive) is at least 8%, rising to 100% (i.e. maximum) if the Company's 3-year average ROCE over 2026-28 (inclusive) is at least 16%, with straight-line vesting between the two points.
The Company also announces the grant of awards under The Savills Deferred Share Plan (No.2 Plan) on 25 August 2026 to PDMRs as follows:
|
PDMR |
Number of shares subject to The Savills Deferred Share Plan (No.2 Plan) awarded to the PDMR on 25 August 2026 |
Total number of shares subject to the Savills deferred share plans following this notification |
|
Rasheed Hassan (PDMR) |
140,343 |
175,397 |
This award will vest in equal proportions on the 4th, 5th and 6th anniversary of the award grant date and is subject to rolled-up dividend shares whereby the number of shares awarded will be increased during the Deferred Period to reflect final and interim dividends paid during the Deferred Period.
|
PDMR |
Number of shares subject to The Savills Deferred Share Plan (No.2 Plan) awarded to the PDMR on 25 August 2026 |
Total number of shares subject to the Savills deferred share plans following this notification |
|
Chris Lee (PDMR) |
23,584 |
71,932 |
These awards have a Deferred Period of three years and are subject to rolled-up dividend shares whereby the number of shares awarded will be increased during the Deferred Period to reflect final and interim dividends paid during the Deferred Period.
The information set out below is provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation No 596/2014.
|
1. |
Details of the Director/ PDMR
|
||
|
(a) |
Name |
1. Simon Shaw 2. Nick Sanderson 3. Rasheed Hassan 4. Chris Lee |
|
|
2. |
Reason for the notification
|
||
|
(a) |
Position/ status |
1. Group Chief Executive/ Director 2. Group Chief Financial Officer/ Director 3. Head of Global Cross Border Investment/ PDMR 4. Group Legal Director & Company Secretary/ PDMR |
|
|
(b) |
Initial notification/ Amendment |
Initial notification |
|
|
3. |
Details of the issuer
|
||
|
(a) |
Name |
Savills plc |
|
|
(b) |
LEI |
213800WXICGMBWHTA933 |
|
|
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
||
|
(a) |
Description of the Financial Instrument |
Savills plc Ordinary Shares of 2.5p each |
|
|
(b) |
Identification code of the Financial Instrument |
GB00B135BJ46 |
|
|
(c) |
Nature of the transaction |
1) Grant of awards over Ordinary Shares in accordance with the Company's Performance Share Plan 2) Grant of awards over Ordinary Shares in accordance with the Company's Deferred Share Plan (No.2 Plan) |
|
|
(d) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
|
1) £nil per share |
1. 75,471 2. 52,830 3. n/a 4. 22,712 |
||
|
2) £nil per share |
1. n/a 2. n/a 3. 140,343 4. 23,584 |
||
|
(e) |
Aggregated information - Aggregated volume - Price |
N/A |
|
|
(f) |
Date of the transaction |
25 August 2026 |
|
|
(g) |
Place of the transaction |
Outside a trading venue |
|
Name of contact and telephone number for queries:
Chris Lee
Group Legal Director & Company Secretary
020 3107 5444
26 August 2026
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ENDRNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.